allergy banner

Videos


Articles


Childhood BCG vaccination seems to selectively protect adult males from COVID-19 infection

Jansson, M.K., Neuber, K., Rudolf, H., Podbielski, A., Virchow, J.C. and Warnke, P. Allergy. First published: 23 November 2021

Mast cells partly contribute to allergic enteritis development: findings in two different mast cell-deficient mice

Blanco-Pérez, F., Gonzalez-Menendez, I., Stassen, M., et al. Allergy. First published: 22 November 2021

Experience with polyethylene glycol allergy-guided risk management for COVID-19 vaccine anaphylaxis

Brockow, K., Mathes, S., Fischer, J., et al. Allergy. First published: 22 November 2021

Role of IL-18 transformed CD274-expressing eosinophils in promoting airway obstruction in experimental asthma

Mishra, A., Majid, D., Kandikattu, H.K., Yadavalli, C.S. and Upparahalli Venkateshaiah, S. Allergy. First published: 20 November 2021

Metabolomics analysis of metabolic patterns in chronic rhinosinusitis with nasal polyps

Ma, Y., Wei, Y., Liu, X., et al. Allergy. First published: 16 November 2021

COVID-19 vaccines tolerated in patients with paclitaxel and docetaxel allergy

Banerji, A., Wolfson, A.R., Robinson, L.B., et al. Allergy. First published: 14 November 2021

Sustained safety and efficacy of ligelizumab in patients with chronic spontaneous urticaria: A one-year extension study

Maurer, M., Giménez-Arnau, A., Bernstein, J.A., et al. Allergy. First published: 13 November 2021

The emerging pathogen Paecilomyces variotii – a novel and important fungal allergen source

Pfeiffer, S., Raith, M., Pascal, M., et al. Allergy. First published: 13 November 2021

Immune-epithelial barrier interactions mediate intestinal adaptation to diverse diets

Avino, G., Riggioni, C. and Comberiati, P. Allergy. First published: 12 November 2021

Epithelial barrier dysfunction in ocular allergy

Singh, N., Diebold, Y., Sahu, S.K. and Leonardi, A. Allergy. First published: 10 November 2021

Impaired skin barrier and allergic sensitization in early infancy

Wärnberg Gerdin, S, Lie, A, Asarnoj, A, et al. Allergy. First published: 05 November 2021

Heterogeneous origin of IgE in atopic dermatitis and psoriasis revealed by B cell receptor repertoire analysis

Luo, L, Luo, Y, Xu, J, et al. Allergy. First published: 05 November 2021

Predicting the recurrence of chronic rhinosinusitis with nasal polyps using nasal microbiota

Zhao, Y., Chen, J., Hao, Y., et al. Allergy. First published: 04 November 2021

Direct oral penicillin challenge for penicillin allergy delabeling as a health services intervention: A multicenter cohort study

Trubiano, J.A., Vogrin, S., Copaescu, A., et al. Allergy. First published: 04 November 2021

GATA-3 and T-bet as diagnostic markers of non-esophageal eosinophilic gastrointestinal disease

Neely, J.L., Reimers, A., Taylor, S., et al. Allergy. First published: 04 November 2021

Citations: 3335

Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)

Bousquet, J., Khaltaev, N., Cruz, A.A., Denburg, J., Fokkens, W.J., Togias, A. et al. Allergy. 2008; 63: 8-160

Citations: 2330

The global burden of asthma: executive summary of the GINA Dissemination Committee Report

Masoli, M., Fabian, D., Holt, S., Beasley, R. Allergy. 2004; 59: 469-478

Citations: 1328

Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China

Zhang, J.-J., Dong, X., Cao, Y.-Y., Yuan, Y.-D., Yan, Y.-Q., Akdis, C., A. and Gao, Y.-D. Allergy. 2020; 75: 1730– 1741

Citations: 1300

A revised nomenclature for allergy - An EAACI position statement from the EAACI nomenclature task force

Johansson, S.G.O., Hourihane, J., Bousquet, J., Bruijnzeel-Koomen, C., Dreborg, S., Haahtela, T. et al. Allergy. 2001; 56: 813-824

Citations: 885

Position Paper - Allergen Standardization and Skin-Tests

Dreborg, S. and Frew, A. Allergy. 1993; 48: 49-54

Citations: 794

Allergenic pollen and pollen allergy in Europe

D’Amato, G., Cecchi, L., Bonini, S., Nunes, C., Annesi-Maesano, I., Behrendt, H. et al. Allergy. 2007; 62: 976-990

Citations: 760

Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE

Humbert, M., Beasley, R., Ayres, J., Slavin, R., Hébert, J., Bousquet, J. et al. Allergy. 2005; 60: 309-316

Citations: 757

The EAACI/GA(2)LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update

Zuberbier, T., Aberer, W., Asero, R., Bindslev-Jensen, C., Brzoza, Z., Canonica, G., W., et al. Allergy. 2014; 69: 868– 887

Citations: 664

Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study

Jacobsen, L., Niggemann, B., Dreborg, S., Ferdousi, H.A., Halken, .S., Høst, A. et al. Allergy. 2007; 62: 943-948

Citations: 617

EAACI Food Allergy and Anaphylaxis Guidelines: diagnosis and management of food allergy

Muraro, A, Werfel, T, Hoffmann-Sommergruber, K, Roberts, G, Beyer, K, Bindslev-Jensen, C, et al. Allergy 2014; 69: 1008– 1025

Citations: 1590

Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China

Zhang, J.-J., Dong, X., Cao, Y.-Y., Yuan, Y.-D., Yan, Y.-Q., Akdis, C., A. and Gao, Y.-D. Allergy. 2020; 75: 1730– 1741

Citations: 350

Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19

Azkur, A.,K., Akdis, M., Azkur, D., Sokolowska, M., van de Veen, W., Brüggen, M.,C. et al. Allergy. 2020; 75: 1564– 1581

Citations: 179

COVID-19 in a designated infectious diseases hospital outside Hubei Province, China

Cai, Q., Huang, D., Ou, P., Yu, H., Zhu, Z., Xia, Z. et al. Allergy. 2020; 75: 1742– 1752

Citations: 167

Distribution of ACE2, CD147, CD26, and other SARS-CoV-2 associated molecules in tissues and immune cells in health and in asthma, COPD, obesity, hypertension, and COVID-19 risk factors

Radzikowska, U., Ding, M., Tan, G., Zhakparov, D., Peng, Y., Wawrzyniak, P. et al. Allergy. 2020; 75: 2828– 2844

Citations: 164

Eleven faces of coronavirus disease 2019

Dong, X., Cao, Y.-Y., Lu, X.-X., Zhang, Du, H., J.-J., Yan, Y.-Q. et al. Allergy. 2020; 75: 1699– 1709

Citations: 77

Distinct characteristics of COVID-19 patients with initial rRT-PCR-positive and rRT-PCR-negative results for SARS-CoV-2

Zhang, J.-j., Cao, Y.-y., Dong, X., Wang, B.-c., Liao, M.-y., Lin, J. et al. Allergy. 2020; 75: 1809-1812

Citations: 56

Is BCG vaccination affecting the spread and severity of COVID-19?

Ozdemir, C., Kucuksezer, U.,C. and Tamay, Z.,U. Allergy. 2020; 75: 1824-1827

Citations: 55

Intranasal corticosteroids in allergic rhinitis in COVID-19 infected patients: An ARIA-EAACI statement

Bousquet, J., Akdis, C.,A., Jutel, M., Bachert, C., Klimek, L., Agache, I. et al. Allergy. 2020; 75: 2440-2444

Citations: 52

Is global BCG vaccination-induced trained immunity relevant to the progression of SARS-CoV-2 pandemic?

Gursel, M. and Gursel, I. Allergy. 2020; 75: 1815-1819

Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19

Azkur, A.,K., Akdis, M., Azkur, D., Sokolowska, M., van de Veen, W., Brüggen, M.,C. et al. Allergy. 2020; 75: 1564– 1581

Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China

Zhang, J.-J., Dong, X., Cao, Y.-Y., Yuan, Y.-D., Yan, Y.-Q., Akdis, C., A. and Gao, Y.-D. Allergy. 2020; 75: 1730– 1741

Unexplained recurrent fever: when is autoinflammation the explanation?

Kallinich, T., Gattorno, M., Grattan, C.,E., de Koning, H.,D., Traidl-Hoffmann, C., Feist, E., et al. Allergy. 2013; 68: 285– 296

The EAACI/GA2LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria

Zuberbier, T., Aberer, W., Asero, R., Abdul Latiff, A., H., Baker, D., Ballmer-Weber, B. et al. Allergy. 2018; 73: 1393- 1414

A compendium answering 150 questions on COVID-19 and SARS-CoV-2

Riggioni, C., Comberiati, P., Giovannini, M., Agache, I., Akdis, M., Alves-Correia, M. et al. Allergy. 2020; 75: 2503– 2541

Cabbage and fermented vegetables: From death rate heterogeneity in countries to candidates for mitigation strategies of severe COVID-19

Bousquet, J., Anto, J.M., Czarlewski, W., Haahtela, T. Fonseca, S.,C., Iaccarino, G. et al. Allergy. 2021; 76: 735– 750

Eleven faces of coronavirus disease 2019

Dong, X., Cao, Y.-Y., Lu, X.-X., Zhang, Du, H., J.-J., Yan, Y.-Q. et al. Allergy. 2020; 75: 1699– 1709

Thirty-six COVID-19 cases preventively vaccinated with mumps-measles-rubella vaccine: All mild course

Larenas-Linnemann, D.,E. and Rodríguez-Monroy, F. Allergy. 2021; 76: 910-914

Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)

Bousquet, J., Khaltaev, N., Cruz, A.A., Denburg, J., Fokkens, W.J., Togias, A. et al. Allergy. 2008; 63: 8-160

Asthma and COVID-19: Is asthma a risk factor for severe outcomes?

Johnston, S.,L. Allergy. 2020; 75: 1543-1545

Childhood BCG vaccination seems to selectively protect adult males from COVID-19 infection

Jansson, M.K., Neuber, K., Rudolf, H., Podbielski, A., Virchow, J.C. and Warnke, P. Allergy. First published: 23 November 2021

Experience with polyethylene glycol allergy-guided risk management for COVID-19 vaccine anaphylaxis

Brockow, K., Mathes, S., Fischer, J., et al. Allergy. First published: 22 November 2021

COVID-19 vaccines tolerated in patients with paclitaxel and docetaxel allergy

Banerji, A., Wolfson, A.R., Robinson, L.B., et al. Allergy. First published: 14 November 2021

Determinants of expression of SARS-CoV-2 entry-related genes in upper and lower airways

Aliee, H., Massip, F., Qi, C., et al. Allergy. First published: 26 October 2021

The value of the basophil activation test in the evaluation of patients reporting allergic reactions to the BNT162b2 mRNA COVID-19 vaccine

Labella, M., Céspedes, J.A., Doña, I., et al. Allergy. First published: 24 October 2021

RBD-IgG levels correlate with protection in residents facing SARS-CoV-2 B.1.1.7 outbreaks

Blain, H., Tuaillon, E., Gamon, L., et al. Allergy. First published: 15 October 2021

Persistence of infectious SARS-CoV-2 particles for up to 37 days in patients with mild COVID-19

Zahn, T., Mhedhbi, I., Hein, S., et al. Allergy. First published: 12 October 2021

What we know and still ignore on COVID-19 immune pathogenesis and a proposal based on the experience of allergic disorders

Maggi, E, Azzarone, BG, Canonica, GW, Moretta, L. Allergy. First published: 28 September 2021

Management of anaphylaxis due to COVID-19 vaccines in the elderly

Bousquet, J., Agache, I., Blain, H., et al. Allergy. 2021; 76: 2952-2964

Predictors of treatment response in chronic spontaneous urticaria

Fok, J.S., Kolkhir, P., Church, M.K. and Maurer, M. Allergy. 2021; 76: 2965-2981

Interleukin-31: The “itchy” cytokine in inflammation and therapy

Datsi, A., Steinhoff, M., Ahmad, F., Alam, M. and Buddenkotte, J. Allergy. 2021; 76: 2982-2997

Markers for the involvement of endothelial cells and the coagulation system in chronic urticaria: A systematic review

Mostmans, Y., De Smedt, K., Richert, B., et al. Allergy. 2021; 76: 2998-3016

Eczema herpeticum in atopic dermatitis

Traidl, S., Roesner, L., Zeitvogel, J. and Werfel, T. Allergy. 2021; 76: 3017-3027

Heterogeneity of pollen food allergy syndrome in seven Southern European countries: The @IT.2020 multicenter study

Lipp, T, Acar Şahin, A, Aggelidis, X, et al. Allergy. 2021; 76: 3041– 3052

Direct assessment of individual skin barrier components by electrical impedance spectroscopy

Mannweiler, R., Bergmann, S., Vidal-y-Sy, S., Brandner, J.M. and Günzel, D. Allergy. 2021; 76: 3094-3106

Prenatal paraben exposure and atopic dermatitis-related outcomes among children

Thürmann, L, Herberth, G, Seiwert, B, et al. Allergy. 2021; 76: 3122– 3132

Free human DNA attenuates the activity of antimicrobial peptides in atopic dermatitis

Kopfnagel, V, Dreyer, S, Zeitvogel, J, et al. Allergy. 2021; 76: 3145– 3154

Nanoarchitectures for efficient IgE cross-linking on effector cells to study amoxicillin allergy

Tesfaye, A., Rodríguez-Nogales, A., Benedé, S., et al. Allergy. 2021; 76: 3183-3193

Sweet syndrome induced by SARS-CoV-2 Pfizer-BioNTech mRNA vaccine

Darrigade, A.-S., Théophile, H., Sanchez-Pena, P., et al. Allergy. 2021; 76: 3194-3196

Type 2 biomarker expression (FeNO and blood eosinophils) is higher in severe adult-onset than in severe early-onset asthma

Lommatzsch, M., Klein, M., Stoll, P. and Virchow, J.C. Allergy. 2021; 76: 3199-3202

Identification of Ulocladium chartarum as an important indoor allergen source

Pfeiffer, S., Sandler, P., Raith, M., et al. Allergy. 2021; 76: 3202-3206

Effects of allergen immunotherapy in the MASK-air study: a proof-of-concept analysis

Pfaar, O., Sousa-Pinto, B., Devillier, P., et al. Allergy. 2021; 76: 3212-3214

Legends of allergy and immunology: Sergio Bonini

Maltese, G. and Rasi, G. Allergy. 2021; 76: 3227-3229

Medical algorithm: Peri-operative management of mastocytosis patients

Bocca-Tjeertes, I.F.A., van de Ven, A.A.J.M., Koppelman, G.H., et al. Allergy. 2021; 76: 3233-3235

Junior Members Corner



Dear Juniors,


Despite these challenging times, EAACI is keeping up with several scientific activities, aiming to being able to meet you all in person soon! The next upcoming appointments are:

- EAACI Pediatric Allergy and Asthma Meeting (PAAM) digital 2021:


It will take place on 12–13 November 2021, in an interactive hybrid format that will allow you to take part in scientific discussions both on-site both from the safety of your home through an innovative and highly interactive concept. The aim is to share new research and findings with internationally renowned experts in the common effort to come up with solutions to the most pressing challenges in the evolving pediatric field.

You can find any information about PAAM by clicking here



- 20th Immunology Winter School on Basic Immunology Research in Allergy and Clinical Immunology:


It will take place from 27 to 30 January 2022, in Semmering (Austria) in an interactive hybrid format. The event will gather 70 young researchers, PhD students and junior postdoc, active in the field of allergy, asthma, clinical immunology/immune deficiency with a focus on basic and/or clinical immunology. The participants will be selected on the basis of the quality of their submitted abstracts.

You can submit your abstract until the 7th of November by clicking here

We look forward to seeing you at our incoming activities and working together to ensure that the highest standards of care are implemented and shared within our specialty.

Best regards,
The Junior Member Assembly


Social Media